# US 2024/0197814 A1 · Materials and methods for the prevention and treatment of viral diseases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197814 A1
- Document ID: US20240197814A1
- Status: Published application
- Kind: A1
- Application number: 18/287,202
- Filed: 2022-04-27
- Published: 2024-06-20
- Earliest claimed: 2021-04-27
- Assignees: Oak Crest Institute of Science
- Applicants: Oak Crest Institute of Science
- Inventors: Marc M. Baum; Manjula Gunawardana
- Web page: https://patentgrep.com/patent/US20240197814A1

## CPC

- A61K 38/10: Peptides having 12 to 20 amino acids {(A61K38/043 - A61K38/046 take precedence)}
- A61P 31/12: Antivirals
- A61K 9/0034: {Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants}
- A61K 31/675: having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A61K 38/162: {from virus}
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 31/14: for RNA viruses
- A61P 31/18: for HIV
- C07K 7/08: having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68)
- C07K 14/005: from viruses
- C12N 2770/24222: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N 2770/24233: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

This disclosure is related to the use of a peptide with antimicrobial properties. The peptide is administered to prevent or treat non-respiratory diseases caused by viruses. A variety of formulations and uses are described as well as methods of manufacture thereof. The formulations are safe and useful in patients—both humans and animals—for the delivery of appropriate bioactive substance(s).

## Claims

### Claim 1

A method of treating or preventing a viral non-respiratory disease, the method comprising administering to a subject in need thereof a peptide comprising
(Formula 1; SEQ ID NO: 1)
X1-X2-X3-X4-X5-X6-X7-X8-X9-X10-X11-X12-X13-X14-X15-X16-X17-
X18,
wherein
X1 is S, K, D, A, N, M, T, or V; X2 is W, I, Y, F, P, L, V, H, M, A, T, or S; X3 is L, W, I, M, V, F, M, A, or T; X4 is R, C, K, Q, H, P, or C; X5 is D, R, I, E, N, or Y; X6 is I, W, V, L, or F; X7 is W, V, Y, F, P, L, V, H, or D; X8 is D, E, N, Y, or S; X9 is W, L, Y, F, P, L, V, or H; X10 is I, V, L, or F; X11 is C, S, A, P, M, H, or T; X12 is E, D, S, Q, Y, or T; X13 is V, F, I, L, A, or M; X14 is L, V, I, M, or F; X15 is S, D, A, N, T, Y, or P; X16 is D, E, N, Y, or S; X17 is F, W, Y, L, P, or H; and X18 is K, E, H, R, P, or Q.

### Claim 2 (depends on 1)

The method of claim 1, wherein the peptide comprises the amino acid sequence of Peptide 346-001.

### Claim 3 (depends on 1)

The method of claim 1, wherein the peptide comprises the amino acid sequence of Peptide 346-001 having one, two, or three amino acid substitutions, the substitutions being selected from the following: the S at position 1 is substituted with K, D, A, N, M, T, or V; the W at position 2 is substituted with I, Y, F, P, L, V, H, M, A, T, or S; the L at position 3 is substituted with W, I, M, V, F, M, A, or T; the R at position 4 is substituted with C, K, Q, H, P, or C; the D at position 5 is substituted with R, I, E, N, or Y; the I at position 6 is substituted with W, V, L, or F; the W at position 7 is substituted with V, Y, F, P, L, V, H, or D; the D at position 8 is substituted with E, N, Y, or S; the W at position 9 is substituted with L, Y, F, P, L, V, or H; the I at position 10 is substituted with V, L, or F; the C at position 11 is substituted with S, A, P, M, H, or T; the E at position 12 is substituted with D, S, Q, Y, or T; the V at position 13 is substituted with F, I, L, A, or M; the L at position 14 is substituted with V, I, M, or F; the S at position 15 is substituted with D, A, N, T, Y, or P; the D at position 16 is substituted with E, N, Y, or S; the F at position 17 is substituted with W, Y, L, P, or H; or the K at position 18 is substituted with E, H, R, P, or Q.

### Claim 4 (depends on 3)

The method of claim 3, wherein the substitutions are selected from the following: the D at position 5 is substituted with I, E, or Y; the I at position 6 is substituted with W, V, L, or F; the W at position 7 is substituted with V, F, or L; the D at position 8 is substituted with E, Y, or S; the I at position 10 is substituted with V, L, or F; the C at position 11 is substituted with S, A, M, H, or T; the V at position 13 is substituted with F, I, L, A, or M; the F at position 17 is substituted with W, Y, L, or H; or the K at position 18 is substituted with H, R, or P.

### Claim 5 (depends on 1, 2, 3, 4)

The method of any one of claims 1 to 4, wherein X1 is S; X2 is W; X3 is L; X9 is W; X12 is E; X14 is L; and X15 is S,

### Claim 6 (depends on 1, 2, 3, 4, 5)

The method of any one of claims 1 to 5, wherein the peptide is modified with a lipophilic moiety via a linker bonded to a lysine, serine, aspartic acid, glutamic acid, or cysteine of the peptide or variant.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The method of any one of claims 1 to 6, wherein the viral non-respiratory disease is an HIV infection.

### Claim 8 (depends on 7)

The method of claim 7, wherein the viral non-respiratory disease is an HIV-1 or HIV-2 infection.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6)

The method of any one of claims 1 to 6, wherein the viral non-respiratory disease is an HSV infection.

### Claim 10 (depends on 9)

The method of claim 9, wherein the viral non-respiratory disease is an HSV-1 or HSV-2 infection.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The method of any one of claims 1 to 10, further comprising administering one or more complementary agents.

### Claim 12 (depends on 11)

The method of claim 11, wherein the one or more complementary agents comprises a contraceptive.

### Claim 13 (depends on 12)

The method of claim 12, wherein the contraceptive is a non-hormonal contraceptive.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The method of any one of claims 1 to 13, wherein the peptide comprises an amino acid sequence of peptides 346-002 through 342-064 set forth in TABLE 1.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The method of any one of claims 1 to 14, wherein X11 is not C.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The method of any one of claims 1 to 15, wherein one or more amino acids are D-amino acids.

### Claim 17

A method of treating or preventing a viral non-respiratory disease, the method comprising administering to a subject in need thereof a peptide comprising
S-W-L-X4-X5-X6-X7-X8-W-X10-X11-E-X13-L-S-D-X17-X18 (Formula 2; SEQ ID NO: 2), wherein X4 is R, G, A, I, L, V, or F; X5 is D, G, I, L, V, F, S, T, E, or Y; X6 is I, A, W, V, L, or F; X7 is W, A, V, Y, F, L, V, H, or D; X8 is D, A, S, E, or Y; X10 is I, A, V, L, or F; X11 is C, S, A, W, M, H, W, R, V, or T; X13 is V, F, I, L, A, or M; X17 is F, W, Y, L, or H; and X18 is K, R, H, A, P, or G.

### Claim 18 (depends on 17)

The method of claim 17, wherein the peptide comprises the amino acid sequence of peptide 346-001 having an amino acid substitution at four amino acid positions selected from positions X4, X5, X6, X7, X8, X10, X11, X13, X17, and X18.

### Claim 19 (depends on 17)

The method of claim 17, wherein the peptide comprises the amino acid sequence of peptide 346-001 having an amino acid substitution at three amino acid positions selected from positions X4, X5, X6, X7, X8, X10, X11, X13, X17, and X18.

### Claim 20 (depends on 17)

The method of claim 17, wherein the peptide comprises the amino acid sequence of peptide 346-001 having an amino acid substitution at two amino acid positions selected from positions X4, X5, X6, X7, X8, X10, X11, X13, X17, and X18.

### Claim 21 (depends on 17)

The method of claim 17, wherein the peptide comprises the amino acid sequence of peptide 346-001 having an amino acid substitution at one amino acid position selected from positions X4, X5, X6, X7, X8, X10, X11, X13, X17, and X18.

### Claim 22 (depends on 18, 19, 20, 21)

The method of any one of claims 18 to 21, wherein at least one of the amino acid substitutions is at position X4, X5, or X6.

### Claim 23 (depends on 18, 19, 20, 21)

The method of any one of claims 18 to 21, wherein at least one of the amino acid substitutions is at position X7, X8, or X10.

### Claim 24 (depends on 18, 19, 20, 21, 22, 23)

The method of any one of claims 18 to 23, wherein at least one of the amino acid substitutions is at position X13, X17, or X18.

### Claim 25 (depends on 18, 19, 20, 21, 22, 23, 24)

The method of any one of claims 18 to 24, wherein the peptide comprises an amino acid substitution at position X11.

### Claim 26 (depends on 17, 18, 19, 20, 21, 22, 23, 24, 25)

The method of any one of claims 17 to 25, wherein if X4 is not R, it is G, A, I, L, V, or F.

### Claim 27 (depends on 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The method of any one of claims 17 to 26, wherein if X5 is not D, it is G, I, L, V, F, S, T, E, or Y; optionally I, E, or Y.

### Claim 28 (depends on 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)

The method of any one of claims 17 to 27, wherein if X6 is not I, it is A, W, V, L, or F;
optionally W, V, L, or F.

### Claim 29 (depends on 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)

The method of any one of claims 17 to 28, wherein if X7 is not W, it is A, V, Y, F, L, V, H, or D; optionally V, Y, F, L, V, H, or D.

### Claim 30 (depends on 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)

The method of any one of claims 17 to 29, wherein if X8 is not D, it is A, S, E, or Y; optionally, E, Y, or S.

### Claim 31 (depends on 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)

The method of any one of claims 17 to 30, wherein if X10 is not I, it is A, V, L, or F; optionally V, L, or F.

### Claim 32 (depends on 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)

The method of any one of claims 17 to 31, wherein if X11 is not C, it is S, A, W, M, H, W, R, V, or T; optionally S, A, M, H, or T.

### Claim 33 (depends on 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)

The method of any one of claims 17 to 32, wherein if X13 is not V, it is F, I, L, A, or M.

### Claim 34 (depends on 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)

The method of any one of claims 17 to 33, wherein if X17 is not F, it is W, Y, L, or H.

### Claim 35 (depends on 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)

The method of any one of claims 17 to 34, wherein if X18 is not K, it is R, H, A, P, or G; optionally R, H, or P.

### Claim 36 (depends on 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

The method of any one of claims 17 to 35, wherein the viral non-respiratory disease is an HIV infection.

### Claim 37 (depends on 36)

The method of claim 36, wherein the viral non-respiratory disease is and HIV-1 or HIV-2 infection.

### Claim 38 (depends on 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

The method of any one of claims 17 to 35, wherein the viral non-respiratory disease is an HSV infection.

### Claim 39 (depends on 38)

The method of claim 38, wherein the viral non-respiratory disease is an HSV-1 or HSV-2 infection.

### Claim 40 (depends on 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)

The method of any one of claims 17 to 39, further comprising administering one or more complementary agents.

### Claim 41 (depends on 40)

The method of claim 40, wherein the one or more complementary agents comprise a contraceptive.

### Claim 42 (depends on 41)

The method of claim 41, wherein the contraceptive is a non-hormonal contraceptive.

### Claim 43 (depends on 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42)

The method of any one of claims 17 to 42, wherein one or more amino acids are D-amino acids.

### Claim 44

A composition comprising a peptide comprising the sequence:
S-W-L-X4-X5-X6-X7-X8-W-X10-X11-E-X13-L-S-D-X17-X18 (Formula 2; SEQ ID NO: 2), wherein X4 is R, G, A, I, L, V, or F; X5 is D, G, I, L, V, F, S, T, E, or Y; X6 is I, A, W, V, L, or F; X7 is W, A, V, Y, F, L, V, H, or D; X8 is D, A, S, E, or Y; X10 is I, A, V, L, or F; X11 is C, S, A, W, M, H, W, R, V, or T; X13 is V, F, I, L, A, or M; X17 is F, W, Y, L, or H; and X18 is K, R, H, A, P, or G, wherein the peptide is not peptide 346-001.

### Claim 45 (depends on 44)

The composition of claim 44, wherein the peptide comprises the amino acid sequence of peptide 346-001 having an amino acid substitution at four amino acid positions selected from positions X4, X5, X6, X7, X8, X10, X11, X13, X17, and X18.

### Claim 46 (depends on 44)

The composition of claim 44, wherein the peptide comprises the amino acid sequence of peptide 346-001 having an amino acid substitution at three amino acid positions selected from positions X4, X5, X6, X7, X8, X10, X11, X13, X17, and X18.

### Claim 47 (depends on 44)

The composition of claim 44, wherein the peptide comprises the amino acid sequence of peptide 346-001 having an amino acid substitution at two amino acid positions selected from positions X4, X5, X6, X7, X8, X10, X11, X13, X17, and X18.

### Claim 48 (depends on 44)

The composition of claim 44, wherein the peptide comprises the amino acid sequence of peptide 346-001 having an amino acid substitution at one amino acid position selected from positions X4, X5, X6, X7, X8, X10, X11, X13, X17, and X18.

### Claim 49 (depends on 45, 46, 47, 48)

The composition of any one of claims 45 to 48, wherein at least one of the amino acid substitutions is at position X4, X5, or X6.

### Claim 50 (depends on 45, 46, 47, 48)

The composition of any one of claims 45 to 48, wherein at least one of the amino acid substitutions is at position X7, X8, or X10.

### Claim 51 (depends on 45, 46, 47, 48, 49, 50)

The composition of any one of claims 45 to 50, wherein at least one of the amino acid composition is at position X13, X17, or X18.

### Claim 52 (depends on 45, 46, 47, 48, 49, 50, 51)

The method of any one of claims 45 to 51, wherein the peptide comprises an amino acid substitution at position X11.

### Claim 53 (depends on 44, 45, 46, 47, 48, 49, 50, 51, 52)

The composition of any one of claims 44 to 52, wherein if X4 is not R, it is G, A, I, L, V, or F.

### Claim 54 (depends on 44, 45, 46, 47, 48, 49, 50, 51, 52, 53)

The composition of any one of claims 44 to 53, wherein if X5 is not D, it is G, I, L, V, F, S, T, E, or Y; optionally I, E, or Y.

### Claim 55 (depends on 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54)

The composition of any one of claims 44 to 54, wherein if X6 is not I, it is A, W, V, L, or F; optionally W, V, L, or F.

### Claim 56 (depends on 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55)

The composition of any one of claims 44 to 55, wherein if X7 is not W, it is A, V, Y, F, L, V, H, or D; optionally V, Y, F, L, V, H, or D.

### Claim 57 (depends on 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56)

The composition of any one of claims 44 to 56, wherein if X8 is not D, it is A, S, E, or Y; optionally, E, Y, or S.

### Claim 58 (depends on 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

The composition of any one of claims 44 to 57, wherein if X10 is not I, it is A, V, L, or F; optionally V, L, or F.

### Claim 59 (depends on 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58)

The composition of any one of claims 44 to 58, wherein if X11 is not C, it is S, A, W, M, H, W, R, V, or T; optionally S, A, M, H, or T.

### Claim 60 (depends on 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59)

The composition of any one of claims 44 to 59, wherein if X13 is not V, it is F, I, L, A, or M.

### Claim 61 (depends on 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60)

The composition of any one of claims 44 to 60, wherein if X17 is not F, it is W, Y, L, or H.

### Claim 62 (depends on 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61)

The composition of any one of claims 44 to 61, wherein if X18 is not K, it is R, H, A, P, or G; optionally R, H, or P.

### Claim 63 (depends on 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62)

The composition of any one of claims 44 to 62, wherein one or more amino acids are D-amino acids.
